Lv41
558 积分 2024-11-15 加入
Efficacy and safety of JAK inhibitors for vitiligo: an updated systematic review and meta-analysis of randomized controlled trials
11小时前
已完结
Differential expression of CXCL9, CXCL10, and IFN‐γ in vitiligo and alopecia areata patients
11小时前
已完结
Improvements in immune/melanocyte biomarkers with JAK3/TEC family kinase inhibitor ritlecitinib in vitiligo
11小时前
已完结
The IFN‐γ‐CXCL9/CXCL10‐CXCR3 axis in vitiligo: Pathological mechanism and treatment
11小时前
已完结
Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: A randomized phase 2b clinical trial
11小时前
已完结
Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial
11小时前
已完结
Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo
11小时前
已完结
Vitiligo: Mechanisms of Pathogenesis and Treatment
11小时前
已完结
Oxidative stress-induced IL-15 trans-presentation in keratinocytes contributes to CD8+ T cells activation via JAK-STAT pathway in vitiligo
11小时前
已完结
Three-dimensional imaging for facial vitiligo: Results from a phase 2 randomized controlled trial investigating upadacitinib in patients with vitiligo
4天前
已完结
皖公网安备34019202002308
